Skip to content
2000
Volume 32, Issue 12
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

Background

It has been widely reported that the use of probiotics has beneficial effects on the prevention and treatment of a wide range of human diseases. Previous clinical trials have investigated the effect of probiotics on oxLDL, but the results are controversial.

Objective

This study aimed to conduct a systematic review and meta-analysis of clinical trials to assess the effect of probiotic consumption on oxLDL levels.

Methods

A comprehensive search was conducted in PubMed, ISI Web of Science, and Scopus using the appropriate search strategy. After the screening, seven studies comparing the effects of probiotic consumption with the control were included in the analysis. A random-effects analysis was used to estimate the overall effect size.

Results

Probiotic supplementation significantly reduced oxLDL (Hedge's: -1.18; 95% CI:-1.85, -0.52) compared to the control group. Subgroup analysis showed that reduction was greater in the unhealthy group compared to healthy subjects (-2.05 -0.84). The results also showed that probiotic supplementation reduced TC by -14.77 mg/dl (95% CI: -24.46, -5.08), LDL-C by -10.03 mg/dl (95% CI: -16.05, -4.001), LDL-C/HDL-C ratio by -0.37 (95% CI: -0.66, 0.07), and TG by -14.86 mg/dl (95% CI: -23.45, -6.28) but the effects on HDL-C and glucose were not significant.

Conclusion

In this study, probiotic supplementation was found to improve oxLDL concentrations and have favorable effects on lipid profiles, but no significant positive effect on HDL-C and glucose was reported. However, the findings should be interpreted with caution due to the low number of included studies.

Loading

Article metrics loading...

/content/journals/cmc/10.2174/0929867331666230815104548
2023-10-19
2025-08-17
Loading full text...

Full text loading...

References

  1. MorelliL. CapursoL. FAO/WHO guidelines on probiotics: 10 years later.J. Clin. Gastroenterol.201246S1S210.1097/MCG.0b013e318269fdd522955349
    [Google Scholar]
  2. FullerR. History and development of probiotics. Probiotics.Springer199218
    [Google Scholar]
  3. ReidG. JassJ. SebulskyM.T. McCormickJ.K. Potential uses of probiotics in clinical practice.Clin. Microbiol. Rev.200316465867210.1128/CMR.16.4.658‑672.200314557292
    [Google Scholar]
  4. BoyleR.J. Robins-BrowneR.M. TangM.L.K. Probiotic use in clinical practice: What are the risks?Am. J. Clin. Nutr.20068361256126410.1093/ajcn/83.6.125616762934
    [Google Scholar]
  5. GuptaV. GargR. Probiotics.Indian J. Med. Microbiol.200927320220910.4103/0255‑0857.5320119584499
    [Google Scholar]
  6. SinghV.P. SharmaJ. BabuS. RizwanullaS.A. SinglaA. Role of probiotics in health and disease: A review.J. Pak. Med. Assoc.201363225325723894906
    [Google Scholar]
  7. DoronS. GorbachS.L. Probiotics: Their role in the treatment and prevention of disease.Expert Rev. Anti Infect. Ther.20064226127510.1586/14787210.4.2.26116597207
    [Google Scholar]
  8. IslamS.U. Clinical uses of probiotics.Medicine.2016955e265810.1097/MD.000000000000265826844491
    [Google Scholar]
  9. MarkowiakP. ŚliżewskaK. Effects of probiotics, prebiotics, and synbiotics on human health.Nutrients.201799102110.3390/nu909102128914794
    [Google Scholar]
  10. Seminario-AmezM. López-LópezJ. Estrugo-DevesaA. Ayuso-MonteroR. Jané-SalasE. Probiotics and oral health: A systematic review.Med. Oral Patol. Oral Cir. Bucal2017223e282e28810.4317/medoral.2149428390121
    [Google Scholar]
  11. BagherniyaM. SahebkarA. ArabA. KarimiE. SathyapalanT. The effect of probiotic and synbiotic consumption on the most prevalent chemotherapy-related complications: A systematic review of current literature.Curr. Med. Chem.202229335462547310.2174/092986732966622041511434335430970
    [Google Scholar]
  12. DavoodvandiA. MarzbanH. GoleijP. SahebkarA. MorshediK. RezaeiS. Mahjoubin-TehranM. TarrahimofradH. HamblinM.R. MirzaeiH. Effects of therapeutic probiotics on modulation of microRNAs.Cell Commun. Signal.2021191410.1186/s12964‑020‑00668‑w33430873
    [Google Scholar]
  13. SahebkarA. JavidH. Karimi-ShahriM. KhorramdelM. MashhadA.S. TabriziA.T. SathyapalanT. AfshariA.R. Probiotics as an adjuvant for management of gastrointestinal cancers through their anti-inflammatory effects: A mechanistic review.Curr. Med. Chem.202330439040610.2174/092986732966622051118574535546761
    [Google Scholar]
  14. MorshediM. HashemiR. MoazzenS. SahebkarA. HosseinifardE.S. Immunomodulatory and anti-inflammatory effects of probiotics in multiple sclerosis: A systematic review.J. Neuroinflammation.201916123110.1186/s12974‑019‑1611‑431752913
    [Google Scholar]
  15. HoffmannA. KleniewskaP. PawliczakR. Antioxidative activity of probiotics.Arch. Med. Sci.202117379280410.5114/aoms.2019.8989434025850
    [Google Scholar]
  16. ShuX. CaoY. LiY. GkerdiA. ReillyJ. TanZ. Association of nutrients, specific dietary patterns, and probiotics with age-related macular degeneration.Curr. Med. Chem.202229406141615810.2174/092986732966622051114281735546762
    [Google Scholar]
  17. LiD. LiuY. YangX. KongL. The role of probiotics and prebiotics in osteolastogenesis and immune relevance.Curr. Med. Chem.202128255228524710.2174/092986732866621031611512633726643
    [Google Scholar]
  18. MolskaM. RegułaJ. Potential mechanisms of probiotics action in the prevention and treatment of colorectal cancer.Nutrients20191110245310.3390/nu1110245331615096
    [Google Scholar]
  19. EsmaeiliS.A. MahmoudiM. MomtaziA.A. SahebkarA. DoulabiH. RastinM. Tolerogenic probiotics: Potential immunoregulators in Systemic Lupus Erythematosus.J. Cell. Physiol.201723281994200710.1002/jcp.2574827996081
    [Google Scholar]
  20. SteinbergD. Atherogenesis in perspective: Hypercholesterolemia and inflammation as partners in crime.Nat. Med.20028111211121710.1038/nm1102‑121112411947
    [Google Scholar]
  21. AydinM.U. AygulN. AltunkeserB.B. UnluA. TanerA. Comparative effects of high-dose atorvastatin versus moderate-dose rosuvastatin on lipid parameters, oxidized-LDL and inflammatory markers in ST elevation myocardial infarction.Atherosclerosis.2015239243944310.1016/j.atherosclerosis.2015.02.00325697576
    [Google Scholar]
  22. LiD. MehtaJ.L. Oxidized LDL, a critical factor in atherogenesis.Elsevier Science2005353354
    [Google Scholar]
  23. VerhoyeE. LangloisM.R. InvestigatorsA. Circulating oxidized low-density lipoprotein: A biomarker of atherosclerosis and cardiovascular risk?Clin. Chem. Lab. Med.200947212813710.1515/CCLM.2009.03719099526
    [Google Scholar]
  24. HartleyA. HaskardD. KhamisR. Oxidized LDL and anti-oxidized LDL antibodies in atherosclerosis – Novel insights and future directions in diagnosis and therapy.Trends Cardiovasc. Med.2019291222610.1016/j.tcm.2018.05.01029934015
    [Google Scholar]
  25. GradinaruD. BorsaC. IonescuC. PradaG.I. Oxidized LDL and NO synthesis-Biomarkers of endothelial dysfunction and ageing.Mech. Ageing Dev.201515110111310.1016/j.mad.2015.03.00325804383
    [Google Scholar]
  26. ZulianiG. MorieriM.L. VolpatoS. VignaG.B. TchC.B. MaggioM. CherubiniA. BandinelliS. GuralnikJ.M. FerrucciL. Determinants and clinical significance of plasma oxidized LDLs in older individuals. A 9 years follow-up study.Atherosclerosis.2013226120120710.1016/j.atherosclerosis.2012.10.02823141584
    [Google Scholar]
  27. PageM.J. McKenzieJ.E. BossuytP.M. BoutronI. HoffmannT.C. MulrowC.D. ShamseerL. TetzlaffJ.M. AklE.A. BrennanS.E. ChouR. GlanvilleJ. GrimshawJ.M. HróbjartssonA. LaluM.M. LiT. LoderE.W. Mayo-WilsonE. McDonaldS. McGuinnessL.A. StewartL.A. ThomasJ. TriccoA.C. WelchV.A. WhitingP. MoherD. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews.Int. J. Surg.20218810590610.1016/j.ijsu.2021.10590633789826
    [Google Scholar]
  28. HigginsJ.P. Cochrane handbook for systematic reviews of interventions version 5.0. 1.The Cochrane Collaboration2008http://www.cochrane-handbookorg
    [Google Scholar]
  29. FuentesM.C. LajoT. CarriónJ.M. CuñéJ. A randomized clinical trial evaluating a proprietary mixture of Lactobacillus plantarum strains for lowering cholesterol1.Med. J. Nutrition Metab.20169212513510.3233/MNM‑160065
    [Google Scholar]
  30. JungS. LeeY.J. KimM. KimM. KwakJ.H. LeeJ.W. AhnY-T. SimJ-H. LeeJ.H. Supplementation with two probiotic strains, Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032, reduced body adiposity and Lp-PLA2 activity in overweight subjects.J. Funct. Foods20151974475210.1016/j.jff.2015.10.006
    [Google Scholar]
  31. KaurS. KullisaarT. MikelsaarM. EisenM. RehemaA. VihalemmT. Successful management of mild atopic dermatitis in adults with probiotics and emollients.Cent. Eur. J. Med.200832215220
    [Google Scholar]
  32. KullisaarT. SongiseppE. MikelsaarM. ZilmerK. VihalemmT. ZilmerM. Antioxidative probiotic fermented goats’ milk decreases oxidative stress-mediated atherogenicity in human subjects.Br. J. Nutr.200390244945610.1079/BJN200389612908907
    [Google Scholar]
  33. MikelsaarM. SeppE. ŠtšepetovaJ. HüttP. ZilmerK. KullisaarT. ZilmerM. Regulation of plasma lipid profile by lactobacillus fermentum (probiotic strain ME-3 DSM14241) in a randomised controlled trial of clinically healthy adults.BMC Nutr.2015112710.1186/s40795‑015‑0020‑z
    [Google Scholar]
  34. VälimäkiI. VuorimaaT. AhotupaM. KekkonenR. KorpelaR. VasankariT. Decreased training volume and increased carbohydrate intake increases oxidized LDL levels.Int. J. Sports Med.201233429129610.1055/s‑0031‑129122322377944
    [Google Scholar]
  35. Sánchez MacarroM. Ávila-GandíaV. Pérez-PiñeroS. CánovasF. García-MuñozA.M. Abellán-RuizM.S. Victoria-MontesinosD. Luque-RubiaA.J. ClimentE. GenovésS. RamonD. ChenollE. López-RománF.J. Antioxidant effect of a probiotic product on a model of oxidative stress induced by high-intensity and duration physical exercise.Antioxidants.202110232310.3390/antiox1002032333671691
    [Google Scholar]
  36. ChoY.A. KimJ. Effect of probiotics on blood lipid concentrations: A meta-analysis of randomized controlled trials.Medicine.20159443e171410.1097/MD.000000000000171426512560
    [Google Scholar]
  37. YanS. TianZ. LiM. LiB. CuiW. Effects of probiotic supplementation on the regulation of blood lipid levels in overweight or obese subjects: A meta-analysis.Food Funct.20191031747175910.1039/C8FO02163E30860222
    [Google Scholar]
  38. DixonA. RobertsonK. YungA. QueM. RandallH. WellalagodageD. CoxT. RobertsonD. ChiC. SunJ. Efficacy of probiotics in patients of cardiovascular disease risk: a systematic review and meta-analysis.Curr. Hypertens. Rep.20202297410.1007/s11906‑020‑01080‑y32860083
    [Google Scholar]
  39. KießlingG. SchneiderJ. JahreisG. Long-term consumption of fermented dairy products over 6 months increases HDL cholesterol.Eur. J. Clin. Nutr.200256984384910.1038/sj.ejcn.160139912209372
    [Google Scholar]
  40. RazmpooshE. JavadiA. EjtahedH.S. MirmiranP. JavadiM. YousefinejadA. The effect of probiotic supplementation on glycemic control and lipid profile in patients with type 2 diabetes: A randomized placebo controlled trial.Diabetes Metab. Syndr.201913117518210.1016/j.dsx.2018.08.00830641692
    [Google Scholar]
  41. BarbosaK.B.F. VolpA.C.P. HermsdorffH.H.M. Navarro-BlascoI. ZuletM.Á. MartínezJ.A. BressanJ. Relationship of oxidized low density lipoprotein with lipid profile and oxidative stress markers in healthy young adults: A translational study.Lipids. Health. Dis.20111016110.1186/1476‑511X‑10‑6121504598
    [Google Scholar]
  42. Burgos AlvesM.I. Avilés PlazaF. Martínez-TomásR. Sánchez-CampilloM. LarquéE. Pérez-LlamasF. MartínezH.P. ParraP.S. Oxidized LDL and its correlation with lipid profile and oxidative stress biomarkers in young healthy Spanish subjects.J. Physiol. Biochem.201066322122710.1007/s13105‑010‑0028‑420652473
    [Google Scholar]
  43. JonesM.L. Tomaro-DuchesneauC. MartoniC.J. PrakashS. Cholesterol lowering with bile salt hydrolase-active probiotic bacteria, mechanism of action, clinical evidence, and future direction for heart health applications.Expert Opin. Biol. Ther.201313563164210.1517/14712598.2013.75870623350815
    [Google Scholar]
  44. KumarM NagpalR KumarR HemalathaR VermaV KumarA Cholesterol-lowering probiotics as potential biotherapeutics for metabolic diseases.Exp. Diabetes. Res.2012201290291710.1155/2012/902917
    [Google Scholar]
  45. PereiraD.I.A. McCartneyA.L. GibsonG.R. An in vitro study of the probiotic potential of a bile-salt-hydrolyzing Lactobacillus fermentum strain, and determination of its cholesterol-lowering properties.Appl. Environ. Microbiol.20036984743475210.1128/AEM.69.8.4743‑4752.200312902267
    [Google Scholar]
  46. GunnessP. GidleyM.J. Mechanisms underlying the cholesterol-lowering properties of soluble dietary fibre polysaccharides.Food. Funct.20101214915510.1039/c0fo00080a21776465
    [Google Scholar]
  47. HeJ. ZhangF. HanY. Effect of probiotics on lipid profiles and blood pressure in patients with type 2 diabetes.Medicine.20179651e916610.1097/MD.000000000000916629390450
    [Google Scholar]
  48. MoR. ZhangX. YangY. Effect of probiotics on lipid profiles in hypercholesterolaemic adults: A meta-analysis of randomized controlled trials.Med. Clin.20191521247348110.1016/j.medcli.2018.09.00730467077
    [Google Scholar]
  49. WuY. ZhangQ. RenY. RuanZ. Effect of probiotic Lactobacillus on lipid profile: A systematic review and meta-analysis of randomized, controlled trials.PLoS. One.2017126e017886810.1371/journal.pone.017886828594860
    [Google Scholar]
  50. PuriS. SharmaS. KurpadA.V. Potential of probiotics in hypercholesterolemia: A meta-analysis.Indian J. Public Health201660428028610.4103/0019‑557X.19585927976649
    [Google Scholar]
  51. BalliniA. SantacroceL. CantoreS. BottalicoL. DipalmaG. TopiS. SainiR. De VitoD. InchingoloF. Probiotics efficacy on oxidative stress values in inflammatory bowel disease: A randomized double-blinded placebo-controlled pilot study.Endocr. Metab. Immune Disord. Drug Targets201919337338110.2174/187153031966618122115035230574857
    [Google Scholar]
  52. HajifarajiM. JahanjouF. AbbasalizadehF. AghamohammadzadehN. AbbasiM.M. DolatkhahN. Effect of probiotic supplements in women with gestational diabetes mellitus on inflammation and oxidative stress biomarkers: A randomized clinical trial.Asia Pac. J. Clin. Nutr.201827358159129737805
    [Google Scholar]
  53. JandhyalaS.M. TalukdarR. SubramanyamC. VuyyuruH. SasikalaM. Nageshwar ReddyD. Role of the normal gut microbiota.World J. Gastroenterol.201521298787880310.3748/wjg.v21.i29.878726269668
    [Google Scholar]
  54. KlarinB. MolinG. JeppssonB. LarssonA. Use of the probiotic Lactobacillus plantarum 299 to reduce pathogenic bacteria in the oropharynx of intubated patients: A randomised controlled open pilot study.Crit. Care2008126R13610.1186/cc710918990201
    [Google Scholar]
  55. WangY. WuY. WangY. XuH. MeiX. YuD. WangY. LiW. Antioxidant properties of probiotic bacteria.Nutrients.20179552110.3390/nu905052128534820
    [Google Scholar]
  56. ArdeshirlarijaniE. Tabatabaei-MalazyO. MohseniS. QorbaniM. LarijaniB. Baradar JaliliR. Effect of probiotics supplementation on glucose and oxidative stress in type 2 diabetes mellitus: A meta-analysis of randomized trials.Daru201927282783710.1007/s40199‑019‑00302‑231691101
    [Google Scholar]
  57. BakhtiaryM. MorvaridzadehM. AgahS. RahimlouM. ChristopherE. ZadroJ.R. HeshmatiJ. Effect of probiotic, prebiotic, and synbiotic supplementation on cardiometabolic and oxidative stress parameters in patients with chronic kidney disease: A systematic review and meta-analysis.Clin. Ther.2021433e71e9610.1016/j.clinthera.2020.12.02133526314
    [Google Scholar]
  58. ChenY. YueR. ZhangB. LiZ. ShuiJ. HuangX. Effects of probiotics on blood glucose, biomarkers of inflammation and oxidative stress in pregnant women with gestational diabetes mellitus: A meta-analysis of randomized controlled trials.Med. Clin.2020154619920610.1016/j.medcli.2019.05.04131630848
    [Google Scholar]
  59. RoshanH. GhaediE. RahmaniJ. BaratiM. NajafiM. KarimzedehM. Effects of probiotics and synbiotic supplementation on antioxidant status: A meta-analysis of randomized clinical trials.Clin. Nutr. ESPEN2019308188
    [Google Scholar]
/content/journals/cmc/10.2174/0929867331666230815104548
Loading
/content/journals/cmc/10.2174/0929867331666230815104548
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher’s website along with the published article.

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test